Beacon Investment Advisory Services, Inc. Biogen Inc. Transaction History

Beacon Investment Advisory Services, Inc.

$2.31 Billion
Q2 2024

A detailed history of Beacon Investment Advisory Services, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 24,661 shares of BIIB stock, worth $4.29 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

24,661

Previous 26,254 6.07%

Holding current value

$4.29 Million

Previous $5.66 Million 0.97%

% of portfolio

0.25%

Previous 0.25%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $303,498 - $377,094	-1,593 Reduced 6.07%	24,661 $5.72 Million
Q1 2024 May 09, 2024	SELL	$212.02 - $267.71 $290,891 - $367,298	-1,372 Reduced 4.97%	26,254 $5.66 Million
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $250,636 - $301,700	-1,126 Reduced 3.92%	27,626 $7.15 Million
Q3 2023 Oct 31, 2023	SELL	$253.3 - $285.89 $242,408 - $273,596	-957 Reduced 3.22%	28,752 $7.39 Million
Q2 2023 Jul 21, 2023	SELL	$275.25 - $318.06 $177,536 - $205,148	-645 Reduced 2.12%	29,709 $8.46 Million
Q1 2023 May 04, 2023	SELL	$256.56 - $292.34 $348,921 - $397,582	-1,360 Reduced 4.29%	30,354 $8.44 Million
Q4 2022 Jan 13, 2023	SELL	$252.44 - $306.72 $1.58 Million - $1.92 Million	-6,254 Reduced 16.47%	31,714 $0
Q3 2022 Oct 20, 2022	SELL	$194.69 - $268.46 $578,423 - $797,594	-2,971 Reduced 7.26%	37,968 $10.1 Million
Q2 2022 Jul 21, 2022	SELL	$187.54 - $223.02 $404,523 - $481,054	-2,157 Reduced 5.01%	40,939 $8.35 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $5.68 Million - $7.16 Million	-29,323 Reduced 40.49%	43,096 $9.08 Million
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $1.47 Million - $1.88 Million	-6,549 Reduced 8.29%	72,419 $17.4 Million
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $1.07 Million - $1.39 Million	-3,777 Reduced 4.56%	78,968 $22.3 Million
Q2 2021 Aug 02, 2021	BUY	$259.0 - $414.71 $239,057 - $382,777	923 Added 1.13%	82,745 $28.7 Million
Q1 2021 May 21, 2021	BUY	$242.95 - $284.63 $1.17 Million - $1.37 Million	4,821 Added 6.26%	81,822 $22.9 Million
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $798,322 - $1.2 Million	-3,379 Reduced 4.2%	77,001 $18.9 Million
Q3 2020 Oct 29, 2020	BUY	$264.77 - $305.71 $2.99 Million - $3.45 Million	11,286 Added 16.33%	80,380 $22.8 Million
Q2 2020 Jul 28, 2020	BUY	$258.66 - $342.55 $3.91 Million - $5.18 Million	15,118 Added 28.01%	69,094 $18.5 Million
Q1 2020 May 05, 2020	SELL	$268.85 - $341.04 $262,128 - $332,514	-975 Reduced 1.77%	53,976 $17.1 Million
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $11.5 Million - $15.9 Million	52,391 Added 2046.52%	54,951 $16.3 Million
Q3 2019 Oct 29, 2019	BUY	$217.44 - $243.88 $80,452 - $90,235	370 Added 16.89%	2,560 $596,000
Q2 2019 Aug 07, 2019	BUY	$219.29 - $241.72 $98,680 - $108,774	450 Added 25.86%	2,190 $512,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $154,947 - $242,356	-715 Reduced 29.12%	1,740 $411,000
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $69,625 - $88,187	-250 Reduced 9.24%	2,455 $739,000
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $7,631 - $9,979	-26 Reduced 0.95%	2,705 $956,000
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $6,695 - $7,979	26 Added 0.96%	2,731 $793,000
Q1 2018 Apr 26, 2018	BUY	$260.13 - $367.91 $68,934 - $97,496	265 Added 10.86%	2,705 $741,000
Q4 2017 Feb 02, 2018	SELL	$307.64 - $344.58 $36,609 - $41,005	-119 Reduced 4.65%	2,440 $777,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $719,462 - $843,676	2,559	2,559 $801,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.

Account

Beacon Investment Advisory Services, Inc. Biogen Inc. Transaction History